It has been shown that tumor vasculogenesis and progression after anti-angiogenic therapies (AATs) and anti-autophagic therapies are due to cross-talk between endothelial and tumor cells via VEGF-enriched exosomes [11]. The gene discussed is VEGFA; the disease is neoplasm.